AAAAAA

   
Results: 1-25 | 26-41

Table of contents of journal:

Results: 1-25/41
Management problems in oncology
Authors: Cleator, SJ Price, P
Citation: Sj. Cleator et P. Price, Management problems in oncology, ADV EXP MED, 465, 2000, pp. 3-10
Adenoviral vectors
Authors: Seth, P
Citation: P. Seth, Adenoviral vectors, ADV EXP MED, 465, 2000, pp. 13-22
Retrovirus vectors
Authors: Takeuchi, Y Pizzato, M
Citation: Y. Takeuchi et M. Pizzato, Retrovirus vectors, ADV EXP MED, 465, 2000, pp. 23-35
Targetable gene delivery vectors
Authors: Hallenbeck, PL Stevenson, SC
Citation: Pl. Hallenbeck et Sc. Stevenson, Targetable gene delivery vectors, ADV EXP MED, 465, 2000, pp. 37-46
Human alpha-fetoprotein transcriptional regulatory sequences - Applicationto gene therapy
Authors: Tamaoki, T
Citation: T. Tamaoki, Human alpha-fetoprotein transcriptional regulatory sequences - Applicationto gene therapy, ADV EXP MED, 465, 2000, pp. 47-56
Tumor-targeted Salmonella - Highly selective delivery vectors
Authors: Bermudes, D Low, B Pawelek, J
Citation: D. Bermudes et al., Tumor-targeted Salmonella - Highly selective delivery vectors, ADV EXP MED, 465, 2000, pp. 57-63
Mutant adenoviruses selectively replication-competent in tumor cells
Authors: Sunamura, M
Citation: M. Sunamura, Mutant adenoviruses selectively replication-competent in tumor cells, ADV EXP MED, 465, 2000, pp. 65-71
Polyoma and papilloma virus vectors for cancer gene therapy
Authors: Krauzewicz, N Griffin, BE
Citation: N. Krauzewicz et Be. Griffin, Polyoma and papilloma virus vectors for cancer gene therapy, ADV EXP MED, 465, 2000, pp. 73-82
Lipid-based vehicles for gene delivery-concept, achievements and future development
Authors: Zarif, L Mannino, RJ
Citation: L. Zarif et Rj. Mannino, Lipid-based vehicles for gene delivery-concept, achievements and future development, ADV EXP MED, 465, 2000, pp. 83-93
The use of skeletal muscle to express genes for the treatment of cancer
Authors: Coe, S Harron, M Winslet, M Goldspink, G
Citation: S. Coe et al., The use of skeletal muscle to express genes for the treatment of cancer, ADV EXP MED, 465, 2000, pp. 95-111
Adhesion molecules in cancer biology
Authors: Ohene-Abuakwa, Y Pignatelli, M
Citation: Y. Ohene-abuakwa et M. Pignatelli, Adhesion molecules in cancer biology, ADV EXP MED, 465, 2000, pp. 115-126
Cell cycle control
Authors: Tannoch, VJ Hinds, PW Tsai, LH
Citation: Vj. Tannoch et al., Cell cycle control, ADV EXP MED, 465, 2000, pp. 127-140
Killer/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death
Authors: Wu, GS Kim, K El-Deiry, WS
Citation: Gs. Wu et al., Killer/DR5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death, ADV EXP MED, 465, 2000, pp. 143-151
Apoptin (R)
Authors: Pietersen, A Noteborn, MHM
Citation: A. Pietersen et Mhm. Noteborn, Apoptin (R), ADV EXP MED, 465, 2000, pp. 153-161
Adenovirus-mediated herpes simplex thymidine kinase gene therapy for braintumors
Authors: Sandmair, AM Vapalahti, M Yla-Herttuala, S
Citation: Am. Sandmair et al., Adenovirus-mediated herpes simplex thymidine kinase gene therapy for braintumors, ADV EXP MED, 465, 2000, pp. 163-170
Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer
Authors: Hung, MC Hortobagyi, GN Ueno, NT
Citation: Mc. Hung et al., Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer, ADV EXP MED, 465, 2000, pp. 171-180
Pre-clinical studies with tumor suppressor genes
Authors: Seth, P
Citation: P. Seth, Pre-clinical studies with tumor suppressor genes, ADV EXP MED, 465, 2000, pp. 183-192
Gene therapy for liver tumours
Authors: Mitry, RR Mansour, MR Havlik, R Habib, NA
Citation: Rr. Mitry et al., Gene therapy for liver tumours, ADV EXP MED, 465, 2000, pp. 193-205
Adenovirus-mediated transfer of a p53 gene in ovarian cancer
Authors: Kigawa, J Terakawa, N
Citation: J. Kigawa et N. Terakawa, Adenovirus-mediated transfer of a p53 gene in ovarian cancer, ADV EXP MED, 465, 2000, pp. 207-214
Eliciting hyperacute rejection as a tumor killing strategy - Herpes amplicon vector transfer of the alpha(1,3)galactosyltransferase gene
Authors: Link, CJ Hellrung, DJ Seregina, T Wang, SM
Citation: Cj. Link et al., Eliciting hyperacute rejection as a tumor killing strategy - Herpes amplicon vector transfer of the alpha(1,3)galactosyltransferase gene, ADV EXP MED, 465, 2000, pp. 217-227
Innate immune therapy for cancer - Screen for molecules capable of activating the innate immune system
Authors: Seya, T Begum, NA Nomura, M Tsuji, S Matsumoto, M Hayashi, A Azuma, I Toyoshima, K
Citation: T. Seya et al., Innate immune therapy for cancer - Screen for molecules capable of activating the innate immune system, ADV EXP MED, 465, 2000, pp. 229-237
Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy
Authors: Madireddi, MT Su, ZZ Young, CSH Goldstein, NI Fisher, PB
Citation: Mt. Madireddi et al., Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy, ADV EXP MED, 465, 2000, pp. 239-261
Antisense IGF and antisense IGF-IR therapy of malignancy
Authors: Wang, H Liu, YJ Wei, LX Guo, YJ
Citation: H. Wang et al., Antisense IGF and antisense IGF-IR therapy of malignancy, ADV EXP MED, 465, 2000, pp. 265-272
Sensitization of tumors to chemotherapy through gene therapy
Authors: Gjerset, RA Mercola, D
Citation: Ra. Gjerset et D. Mercola, Sensitization of tumors to chemotherapy through gene therapy, ADV EXP MED, 465, 2000, pp. 273-291
Design and testing of ribozymes for cancer gene therapy
Authors: Norris, JS Hoel, B Voeks, D Maggouta, F Dahm, M Pan, WH Clawson, G
Citation: Js. Norris et al., Design and testing of ribozymes for cancer gene therapy, ADV EXP MED, 465, 2000, pp. 293-301
Risultati: 1-25 | 26-41